SLC10A6 and kidney cancer: As shown in Figure 11A, we observed that the mRNA expression level of ETV4 was significantly increased and the expression levels of SH2B3, FATE1, GRK5, MALL, HRH2, SEMA3G and SLC10A6 were decreased prominently in kidney cancer cells when compared with HK2 cell line.